We are committed to establishing a standard of care missing from the medical cannabis industry until now.

Although interest in cannabis as a credible, reliable option for pain management is growing rapidly, few options currently exist for patients who may feel apprehensive about self-educating and self-dosing in the hopes of a little relief. Backed by nearly three years of research and development, Resolve is set to become the leading medical solution for accurate, metered cannabis care.

Our debut product, Breeze, allows for greater patient confidence and consistency. The proprietary solution and cloud-based platform addresses issues with cannabis delivery currently available for medical patients. The cannabis pod is selected based on the associated medical condition then inserted into the Breeze vaporizer. The patient experience is then tracked through a mobile application with all data is securely stored for sharing with doctors, pharmacists and other caregivers.

“It all started with a single mom, a parent from my own community, who confided in me that cannabis was the only thing that got her through chemotherapy. I couldn’t stop thinking about it – which led to my own research and a series of intensive development sprints over the course of the past three years, leading to where we are today with Breeze.”

Rob Adelson - CEO

Latest News

June 27, 2017 in News

LeafCann Group and Resolve Digital Health Inc. Partner to Expand Australian Medical Cannabis Market

LeafCann Group and Resolve Digital Health Inc. Partner to Expand Australian Medical Cannabis Market Agreement Paves Way for Significant Canadian-Australia Medical Cannabis Collaboration TORONTO, CANADA and MELBOURNE, AUSTRALIA – June…

Read More

Contact RDH

We are expanding fast and are always eager to hear from patients, partners, suppliers and potential investors or job seekers interested in leading edge cannabis products and solutions.

Contact